Cargando…

Effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia

BACKGROUND: Italian pediatric antimicrobial prescription rates are among the highest in Europe. As a first step in an Antimicrobial Stewardship Program, we implemented a Clinical Pathway (CP) for Community Acquired Pneumonia with the aim of decreasing overall prescription of antibiotics, especially...

Descripción completa

Detalles Bibliográficos
Autores principales: Donà, Daniele, Zingarella, Silvia, Gastaldi, Andrea, Lundin, Rebecca, Perilongo, Giorgio, Frigo, Anna Chiara, Hamdy, Rana F., Zaoutis, Theoklis, Da Dalt, Liviana, Giaquinto, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831636/
https://www.ncbi.nlm.nih.gov/pubmed/29489898
http://dx.doi.org/10.1371/journal.pone.0193581
_version_ 1783303174469189632
author Donà, Daniele
Zingarella, Silvia
Gastaldi, Andrea
Lundin, Rebecca
Perilongo, Giorgio
Frigo, Anna Chiara
Hamdy, Rana F.
Zaoutis, Theoklis
Da Dalt, Liviana
Giaquinto, Carlo
author_facet Donà, Daniele
Zingarella, Silvia
Gastaldi, Andrea
Lundin, Rebecca
Perilongo, Giorgio
Frigo, Anna Chiara
Hamdy, Rana F.
Zaoutis, Theoklis
Da Dalt, Liviana
Giaquinto, Carlo
author_sort Donà, Daniele
collection PubMed
description BACKGROUND: Italian pediatric antimicrobial prescription rates are among the highest in Europe. As a first step in an Antimicrobial Stewardship Program, we implemented a Clinical Pathway (CP) for Community Acquired Pneumonia with the aim of decreasing overall prescription of antibiotics, especially broad-spectrum. MATERIALS AND METHODS: The CP was implemented on 10/01/2015. We collected antibiotic prescribing and outcomes data from children aged 3 months-15 years diagnosed with CAP from 10/15/2014 to 04/15/2015 (pre-intervention period) and from 10/15/2015 to 04/15/2016 (post-intervention period). We assessed antibiotic prescription differences pre- and post-CP, including rates, breadth of spectrum, and duration of therapy. We also compared length of hospital stay for inpatients and treatment failure for inpatients and outpatients. Chi-square and Fisher’s exact test were used to compare categorical variables and Wilcoxon rank sum test was used to compare quantitative outcomes. RESULTS: 120 pre- and 86 post-intervention clinic visits were identified with a diagnosis of CAP. In outpatients, we observed a decrease in broad-spectrum regimens (50% pre-CP vs. 26.8% post-CP, p = 0.02), in particular macrolides, and an increase in narrow-spectrum (amoxicillin) post-CP. Post-CP children received fewer antibiotic courses (median DOT from 10 pre-CP to 8 post-CP, p<0.0001) for fewer days (median LOT from 10 pre-CP to 8 post-CP, p<0.0001) than their pre-CP counterparts. Physicians prescribed narrow-spectrum monotherapy more frequently than broad-spectrum combination therapy (DOT/LOT ratio 1.157 pre-CP vs. 1.065 post-CP). No difference in treatment failure was reported before and after implementation (2.3% pre-CP vs. 11.8% post-CP, p = 0.29). Among inpatients we also noted a decrease in broad-spectrum regimens (100% pre-CP vs. 66.7% post-CP, p = 0.02) and the introduction of narrow-spectrum regimens (0% pre-CP vs. 33.3% post-CP, p = 0.02) post-CP. Hospitalized patients received fewer antibiotic courses post-CP (median DOT from 18.5 pre-CP to 10 post-CP, p = 0.004), while there was no statistical difference in length of therapy (median LOT from 11 pre-CP to 10 post-CP, p = 0.06). Days of broad spectrum therapy were notably lower post-CP (median bsDOT from 17 pre-CP to 4.5 post-CP, p <0.0001). No difference in treatment failure was reported before and after CP implementation (16.7% pre-CP vs. 15.4% post-CP, p = 1). CONCLUSIONS: Introduction of a CP for CAP in a Pediatric Emergency Department led to reduction of broad-spectrum antibiotic prescriptions, of combination therapy and of duration of treatment both for outpatients and inpatients.
format Online
Article
Text
id pubmed-5831636
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-58316362018-03-19 Effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia Donà, Daniele Zingarella, Silvia Gastaldi, Andrea Lundin, Rebecca Perilongo, Giorgio Frigo, Anna Chiara Hamdy, Rana F. Zaoutis, Theoklis Da Dalt, Liviana Giaquinto, Carlo PLoS One Research Article BACKGROUND: Italian pediatric antimicrobial prescription rates are among the highest in Europe. As a first step in an Antimicrobial Stewardship Program, we implemented a Clinical Pathway (CP) for Community Acquired Pneumonia with the aim of decreasing overall prescription of antibiotics, especially broad-spectrum. MATERIALS AND METHODS: The CP was implemented on 10/01/2015. We collected antibiotic prescribing and outcomes data from children aged 3 months-15 years diagnosed with CAP from 10/15/2014 to 04/15/2015 (pre-intervention period) and from 10/15/2015 to 04/15/2016 (post-intervention period). We assessed antibiotic prescription differences pre- and post-CP, including rates, breadth of spectrum, and duration of therapy. We also compared length of hospital stay for inpatients and treatment failure for inpatients and outpatients. Chi-square and Fisher’s exact test were used to compare categorical variables and Wilcoxon rank sum test was used to compare quantitative outcomes. RESULTS: 120 pre- and 86 post-intervention clinic visits were identified with a diagnosis of CAP. In outpatients, we observed a decrease in broad-spectrum regimens (50% pre-CP vs. 26.8% post-CP, p = 0.02), in particular macrolides, and an increase in narrow-spectrum (amoxicillin) post-CP. Post-CP children received fewer antibiotic courses (median DOT from 10 pre-CP to 8 post-CP, p<0.0001) for fewer days (median LOT from 10 pre-CP to 8 post-CP, p<0.0001) than their pre-CP counterparts. Physicians prescribed narrow-spectrum monotherapy more frequently than broad-spectrum combination therapy (DOT/LOT ratio 1.157 pre-CP vs. 1.065 post-CP). No difference in treatment failure was reported before and after implementation (2.3% pre-CP vs. 11.8% post-CP, p = 0.29). Among inpatients we also noted a decrease in broad-spectrum regimens (100% pre-CP vs. 66.7% post-CP, p = 0.02) and the introduction of narrow-spectrum regimens (0% pre-CP vs. 33.3% post-CP, p = 0.02) post-CP. Hospitalized patients received fewer antibiotic courses post-CP (median DOT from 18.5 pre-CP to 10 post-CP, p = 0.004), while there was no statistical difference in length of therapy (median LOT from 11 pre-CP to 10 post-CP, p = 0.06). Days of broad spectrum therapy were notably lower post-CP (median bsDOT from 17 pre-CP to 4.5 post-CP, p <0.0001). No difference in treatment failure was reported before and after CP implementation (16.7% pre-CP vs. 15.4% post-CP, p = 1). CONCLUSIONS: Introduction of a CP for CAP in a Pediatric Emergency Department led to reduction of broad-spectrum antibiotic prescriptions, of combination therapy and of duration of treatment both for outpatients and inpatients. Public Library of Science 2018-02-28 /pmc/articles/PMC5831636/ /pubmed/29489898 http://dx.doi.org/10.1371/journal.pone.0193581 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Donà, Daniele
Zingarella, Silvia
Gastaldi, Andrea
Lundin, Rebecca
Perilongo, Giorgio
Frigo, Anna Chiara
Hamdy, Rana F.
Zaoutis, Theoklis
Da Dalt, Liviana
Giaquinto, Carlo
Effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia
title Effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia
title_full Effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia
title_fullStr Effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia
title_full_unstemmed Effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia
title_short Effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia
title_sort effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831636/
https://www.ncbi.nlm.nih.gov/pubmed/29489898
http://dx.doi.org/10.1371/journal.pone.0193581
work_keys_str_mv AT donadaniele effectsofclinicalpathwayimplementationonantibioticprescriptionsforpediatriccommunityacquiredpneumonia
AT zingarellasilvia effectsofclinicalpathwayimplementationonantibioticprescriptionsforpediatriccommunityacquiredpneumonia
AT gastaldiandrea effectsofclinicalpathwayimplementationonantibioticprescriptionsforpediatriccommunityacquiredpneumonia
AT lundinrebecca effectsofclinicalpathwayimplementationonantibioticprescriptionsforpediatriccommunityacquiredpneumonia
AT perilongogiorgio effectsofclinicalpathwayimplementationonantibioticprescriptionsforpediatriccommunityacquiredpneumonia
AT frigoannachiara effectsofclinicalpathwayimplementationonantibioticprescriptionsforpediatriccommunityacquiredpneumonia
AT hamdyranaf effectsofclinicalpathwayimplementationonantibioticprescriptionsforpediatriccommunityacquiredpneumonia
AT zaoutistheoklis effectsofclinicalpathwayimplementationonantibioticprescriptionsforpediatriccommunityacquiredpneumonia
AT dadaltliviana effectsofclinicalpathwayimplementationonantibioticprescriptionsforpediatriccommunityacquiredpneumonia
AT giaquintocarlo effectsofclinicalpathwayimplementationonantibioticprescriptionsforpediatriccommunityacquiredpneumonia